Efficacy and Safety of Nevirapine + Kivexa (Abacavir/Lamivudine) as a Simplification Strategy for HIV Patients With Undetectable Viral Load

Alfonso Cabello(Hospital Universitario Fundación Jiménez Díaz), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Frances M. K. Williams(Williams & Associates), José Sanz Moreno(Hospital Universitario Príncipe de Asturias)
JAIDS Journal of Acquired Immune Deficiency Syndromes
October 15, 2011
10.1097/qai.0b013e31822ccfe3
Cited by 3

Related Papers

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor
|Circulation|2010|363
Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain
|PLoS ONE|2018|179
Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
|The Journal of Infectious Diseases|2007|173
Hospital-Acquired Infectious Endocarditis Not Associated with Cardiac Surgery: An Emerging Problem
|Clinical Infectious Diseases|1995|170
The Spectrum of Cardiovascular Infections due to Salmonella enterica
|Medicine|2004|155